Is BLU or RYLD a better dividend investment in 2026?

BLU currently yields 13.56% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: BLU offers higher current income.

What is the dividend yield difference between BLU and RYLD?

BLU has a forward dividend yield of 13.56% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 1.17 percentage points.

Home › Compare › BLU vs RYLD

BLU vs RYLD: Dividend Comparison 2026

BLU yields 13.56% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BLU wins by $3.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

BLU

● Live price

13.56%

Share price

$14.75

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$48.8K

Annual income

$3,147.85

Full BLU calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — BLU vs RYLD

📍 BLU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BLU	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BLU + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BLU pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLU

Annual income on $10K today (after 15% tax)

$1,152.93/yr

After 10yr DRIP, annual income (after tax)

$2,675.67/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, BLU beats the other by $395.14/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLU + RYLD for your $10,000?

BLU: 50%RYLD: 50%

100% RYLD50/50100% BLU

Portfolio after 10yr

$47.0K

Annual income

$2,915.42/yr

Blended yield

6.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BLU right now

BLU

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$14.75

+0.0% upside vs current

Range: $14.75 — $14.75

Altman Z

1.3

Piotroski

3/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLU buys

RYLD buys

No recent congressional trades found for BLU or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBLURYLD

Forward yield	13.56% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$48.8K ✓	$45.3K
Annual income after 10y	$3,147.85 ✓	$2,682.98
Total dividends collected	$22.2K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BLU vs RYLD ($10,000, DRIP)

Year	BLU Portfolio	BLU Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$12,056	$1,356.39	$11,939	$1,239.34	+$117.00 → BLU
2	$14,429	$1,528.34	$14,158	$1,382.89	+$271.00 → BLU
3	$17,148	$1,709.40	$16,682	$1,532.59	+$466.00 → BLU
4	$20,247	$1,898.67	$19,537	$1,687.64	+$710.00 → BLU
5	$23,760	$2,095.14	$22,752	$1,847.20	+$1.0K → BLU
6	$27,720	$2,297.76	$26,355	$2,010.43	+$1.4K → BLU
7	$32,166	$2,505.44	$30,376	$2,176.45	+$1.8K → BLU
8	$37,135	$2,717.07	$34,847	$2,344.43	+$2.3K → BLU
9	$42,666	$2,931.56	$39,800	$2,513.54	+$2.9K → BLU
10	$48,801	$3,147.85	$45,269	$2,682.98	+$3.5K → BLU

BLU vs RYLD: Complete Analysis 2026

BLU — Stock

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.

Full BLU Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this BLU vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLU vs SCHD BLU vs JEPI BLU vs O BLU vs KO BLU vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.